THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH for THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Environment/Superfund ENV
Environmental Protection Agency's Transparency Rule Cost / Benefit analysis
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRITTANY MEYER | Senior Associate Director, Public Policy |
Veterans VET
Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) at the Department of Veterans Affairs and the Medical Services Account H.R.663 / S. 191 - Burn Pits Accountability Act H.R. 2500- National Defense Authorization Act for Fiscal year 2020
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRITTANY MEYER | Senior Associate Director, Public Policy |
Medicare/Medicaid MMM
H.R. 7078, the Evaluating Disparities and Outcomes of Telehealth During the COVID-19 Emergency Act of 2020 Medicaid non-emergency medical transportation (NEMT) S.475 - RxCAP Act of 2019 H.R. 945/S. 286, the Mental Health Access Improvement Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| TED THOMPSON | Senior Vice President, Public Policy |
Budget/Appropriations BUD
Parkinsons Disease Research, Education and Clinical Centers (PADRECCs) at the Department of Veterans Affairs and the Medical Services Account Federal appropriations for National Institutes of Health and the Centers for Disease Control; Federal appropriations for Department of Defense Medical Research Programs Federal appropriations for Food and Drug Administration Federal appropriations for Department of Defense Medical Research Programs The Coronavirus Aid, Relief, and Economic Security Act (CARES)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRITTANY MEYER | Senior Associate Director, Public Policy |
| TED THOMPSON | Senior Vice President, Public Policy |
Pharmacy PHA
Support of pharmaceutical innovation S.475 - RxCAP Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRITTANY MEYER | Senior Associate Director, Public Policy |
| TED THOMPSON | Senior Vice President, Public Policy |
Agriculture AGR
Environmental agitators of Parkinson's disease Pre-introduced version of Protect Americas Children from Toxic Pesticides Act HR 230 Ban Toxic Pesticides Act of 2019 HR 3817 Protect Against Paraquat Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRITTANY MEYER | Senior Associate Director, Public Policy |
| TED THOMPSON | Senior Vice President, Public Policy |
Health Issues HCR
H.R.7078, the Evaluating Disparities and Outcomes of Telehealth During the COVID-19 Emergency Act of 2020 Expand eligibility for paid family and medical leave for high-risk individuals during the pandemic Telehealth guidelines for making the flexibilities permanent Medicaid non-emergency medical transportation (NEMT) Improving Seniors Timely Access to Care Act (H.R. 3107) S. 1384, the Prescription Drug Rebate Reform Act of 2019 S.475 - RxCAP Act of 2019 H.R. 945/S. 286, the Mental Health Access Improvement Act of 2019 H.R. 601 - Medical Cannabis Research Act of 2019 Support of an out-of-pocket spending cap for Medicare Part D Support for Value Based Arrangements in Medicare and Medicaid General information about Parkinson's disease, the need for research funding, and protecting access to care
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON POLACEK New | Public Policy Officer |
| TED THOMPSON | Senior Vice President, Public Policy |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.